This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (March 2024) |
Names | |
---|---|
IUPAC name (2S)-2,5-bis-3,5-dihydroxy-2-methyl-7-oxo-4,9-dihydro-3H-pyranoisoindol-8-yl]pentanoic acid | |
Other names
| |
Identifiers | |
3D model (JSmol) | |
PubChem CID | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C51H68N2O10 |
Molar mass | 869.109 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
BIIB131 (also known as SMTP-7 or TMS-007) is a prothrombolytic small-molecule drug developed by Biogen for acute ischemic stroke.
References
- Yuan, Long; Jiang, Di; Pinkham, Andrew; Kirkland, Melissa (November 2023). "Development, validation and application of a capillary microsampling LC–MS/MS method for the quantification of BIIB131 (SMTP-7) in rat plasma". Journal of Pharmaceutical and Biomedical Analysis. 236: 115752. doi:10.1016/j.jpba.2023.115752. PMID 37769527.
- Kostrubsky, Vick; Liu, Ying; Muste, Cathy; Gu, Chungang; Kirkland, Melissa; Nishimura, Naoko; Hasegawa, Keiko; Hasumi, Keiji; Yuan, Long (December 2023). "Preclinical safety, toxicokinetics and metabolism of BIIB131, a novel prothrombolytic agent for acute stroke". Regulatory Toxicology and Pharmacology. 145: 105498. doi:10.1016/j.yrtph.2023.105498. PMID 37778433. S2CID 263297651.
- Wang, Bo; Lin, Yiqing (2022). "Absolute configuration determination of SMTP-7 via microcrystal electron diffraction (MicroED)". Chemical Communications. 58 (94): 13071–13074. doi:10.1039/D2CC05218K. PMID 36305866. S2CID 253184088.